TECHNOLOGY FUNDING SECURED INVESTORS III
10-K, 1996-03-25
FINANCE SERVICES
Previous: ACHIEVEMENT FUNDS TRUST, 24F-2NT/A, 1996-03-25
Next: FRANKLIN SELECT REAL ESTATE INCOME FUND, 424B1, 1996-03-25



<PAGE>
                             UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C.  20549

                              FORM 10-K

[X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
     EXCHANGE ACT OF 1934

                 For The Year Ended December 31, 1995

                                    OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

            For the transition period from N/A to N/A
                                           ---    ---

                      Commission File No. 0-19221

                TECHNOLOGY FUNDING SECURED INVESTORS III,
                 AN INCOME AND GROWTH PARTNERSHIP, L.P.
          ------------------------------------------------------
          (Exact name of Registrant as specified in its charter)

          CALIFORNIA                            94-3081010
- -------------------------------    ----------------------------------
(State or other jurisdiction of   (I.R.S. Employer Identification No.)
incorporation or organization) 

2000 Alameda de las Pulgas, Suite 250
San Mateo, California                                            94403
- ---------------------------------------                       --------
(Address of principal executive offices)                    (Zip Code)

                              (415) 345-2200
             --------------------------------------------------
            (Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:  None
Securities registered pursuant to Section 12(g) of the Act:  Limited
Partnership Units

Indicate by check mark whether the Registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the Securities 
Exchange Act of 1934 during the preceding 12 months (or for such 
shorter period that the Registrant was required to file such reports), 
and (2) has been subject to such filing requirements for the past 90 
days.                                                    Yes X  No   
                                                            ---   ---

Indicate by check mark if disclosure of delinquent filers pursuant to 
Item 405 of Regulation S-K is not contained herein, and will not be 
contained, to the best of registrant's knowledge, in definitive proxy 
or information statements incorporated by reference in Part III of 
this Form 10-K or any amendment to this Form 10-K.          [   ]

No resale market for the units of limited partnership interests 
("Units") exists, and therefore the market value of such Units cannot 
be determined.

Documents incorporated by reference:  Portions of the Prospectus dated 
March 16, 1989 forming a part of Registration Statement No. 33-26190 
filed pursuant to Rule 424(c) of the General Rules and Regulations 
under the Securities Act of 1933, are incorporated by reference in 
Parts I and III hereof.  Portions of the Prospectus of Technology 
Funding Medical Partners I, L.P., as modified by Cumulative Supplement 
No. 4 dated January 4, 1995, forming a part of the May 3, 1993 Pre-
Effective Amendment No. 3 to the Form N-2 Registration Statement No. 
33-54002 dated October 30, 1992, incorporated by reference in Part III 
hereof.

<PAGE>
                                PART I

Item 1.  BUSINESS
- ------   --------

Technology Funding Secured Investors III, An Income and 
Growth Partnership, L.P. (hereinafter referred to as the 
"Partnership" or the "Registrant") was formed as a California 
limited partnership on December 9, 1988.  The business of the 
Partnership is to provide loans secured by equipment and 
other assets to new and developing companies and to acquire 
equity interests in these companies as described in the 
"Summary of the Offering" and "Business of the Partnership" 
sections of the Prospectus dated March 16, 1989 that forms a 
part of Registrant's Form S-1 Registration Statement No. 33-
26190 (such Prospectus, as supplemented, is hereinafter 
referred to as the "Prospectus"), which sections are 
incorporated herein by reference.  Additional characteristics 
of the Partnership's business are discussed in the "Risk 
Factors" and "Conflicts of Interest" sections of the 
Prospectus, which sections are also incorporated herein by 
reference.  The Partnership's Amended and Restated Limited 
Partnership Agreement ("Partnership Agreement") provides that 
the Partnership will continue until December 31, 1998, unless 
further extended for up to two additional two-year periods 
from such date if the General Partners so determine or the 
Partnership may be dissolved sooner.

Item 2.  PROPERTIES
- ------   ----------

The Registrant has no material physical properties.

Item 3.  LEGAL PROCEEDINGS
- ------   -----------------

Except as disclosed in Note 10 to the financial statements, 
there are no other material pending legal proceedings to 
which the Registrant is party or of which any of its property 
is the subject, other than ordinary routine litigation 
incidental to the business of the Partnership.

Item 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
- ------   ---------------------------------------------------

No matter was submitted to a vote of the holders of units of 
limited partnership interests ("Units") during 1995.

                               PART II

Item 5.  MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED   
- ------   -------------------------------------------------
         STOCKHOLDER MATTERS
         ----------- -------

(a)  There is no established public trading market for the 
Units.

(b)  At December 31, 1995, there were 5,191 record holders of 
Units.

(c)  The Registrant, being a partnership, does not pay 
dividends.  Cash distributions, however, may be made to 
the partners in the Partnership pursuant to the 
Registrant's Partnership Agreement.

Item 6.  SELECTED FINANCIAL DATA
- ------   -----------------------



<TABLE>
<CAPTION>
                                       For the Years Ended and as of December 31,
                              ----------------------------------------------------------------
<S>                           <C>           <C>          <C>          <C>          <C>
                                    1995       1994         1993         1992         1991
                                    ----       ----         ----         ----         ----

Total income                  $ 1,589,346    1,512,194    1,367,023    2,806,215    3,009,081
Net operating income              729,824      569,968      313,492    1,092,444    1,501,349
Net realized gain from sales
 of equity investments          2,454,187      425,431      476,335      127,957      138,399
Realized losses from
 investment write-downs        (4,508,628)  (4,082,445)  (1,902,799)    (276,284)     (50,552)
Net realized (loss) income     (1,324,617)  (3,087,046)  (1,112,972)     944,117    1,589,196
Change in net unrealized 
  fair value:
 Equity investments             2,786,658   (2,281,481)     209,851   (1,506,486)     987,225
 Secured notes receivable        (212,000)    (139,000)    (118,000)  (2,945,926)    (496,887)
Net income (loss)               1,250,041   (5,507,527)  (1,021,121)  (3,508,295)   2,079,534
Net realized (loss) income
 per Unit                              (3)          (8)          (3)           2            4
Total assets                   13,586,829   12,058,547   18,141,077   22,919,883   29,978,859
Distributions declared           (391,777)    (574,167)  (2,445,411)  (3,646,141)  (3,377,394)


</TABLE>




Refer to financial statement notes entitled "Summary of 
Significant Accounting Policies" and "Allocation of Profits 
and Losses" for a description of the method of calculation of 
net realized (loss) income per Unit.

Item 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
- ------   -----------------------------------------------------------
         AND RESULTS OF OPERATIONS
         -------------------------

         Liquidity and Capital Resources
         -------------------------------

In 1995, net cash provided by operating activities totaled 
$803,726.  The Partnership paid management fees of $201,640 
to the Managing General Partner, reimbursed related parties 
for operating expenses of $227,729 and received $876 in net 
loan participations from affiliated partnerships.  Other 
operating expenses of $365,059 were paid and $1,590,420 and 
$6,858 in interest and other income, respectively, were 
received.  

In 1995, the Partnership issued $1,216,335 in secured notes 
receivable primarily to portfolio companies in the computers 
and computer equipment and medical industries.  Repayments of 
secured notes receivable provided cash of $2,170,864.  In 
addition, the Partnership received proceeds totaling 
$3,366,988 from sales of equity investments.  As of December 
31, 1995, the Partnership was committed to fund up to an 
additional $306,000 on term note financings to existing 
borrowing companies.

Datalogix International, Inc. and Celeritek, Inc. completed 
their initial public offerings ("IPOs") in 1995.  Hybridon, 
Inc. completes its IPO in early 1996.  The Partnership sold 
its Datalogix International, Inc. investment for total 
proceeds of $228,812.  Although the Celeritek, Inc. and 
Hybridon, Inc. shares are subject to selling restrictions, 
their IPOs indicate potential future liquidity.

In December 1995, the Partnership sold its remaining 50% 
ownership in Imagine Publishing, Inc. (formerly GP 
Publishing, Inc.) for net cash proceeds of $2,450,316.  The 
first half of the investment was sold in 1993 for net 
proceeds of $572,917.

All management fees which are due have been paid through 
December 31, 1995.  Management fees are paid to the extent 
that the aggregate amount of all proceeds (including those 
from warrants exercised without cash) received by the 
Partnership from the sale or other disposition of borrowing 
company equities, plus the aggregate fair market value of any 
equity securities distributed to the partners, exceeds the 
total management fee payable as defined in the Partnership 
Agreement.

Cash and cash equivalents at December 31, 1995 were 
$7,046,622.  Operating cash reserves combined with investment 
sale proceeds, interest income received on short-term 
investments and repayments of secured notes receivable are 
expected to be sufficient to fund Partnership operations and 
loan requirements of existing borrowing companies through the 
next twelve months.

Results of Operations
- ---------------------

1995 compared to 1994
- ---------------------

Net income was $1,250,041 in 1995, compared to a net loss of 
$5,507,527 in 1994.  The change was mainly due to a 
$5,068,139 increase in the change in net unrealized fair 
value of equity investments, a $2,028,756 increase in net 
realized gain from sales of equity investments, partially 
offset by a $426,183 increase in realized losses from 
investment write-downs.

In 1995, the increase in equity investment fair value of 
$2,786,658 was primarily due to the reversal of unrealized 
losses, which were realized from investment write-downs for 
portfolio companies in the medical and retail/consumer 
products industries.  In 1994, the decrease of $2,281,481 was 
primarily due to a net decrease in the fair value of the 
Partnership's holdings in a portfolio company in the medical 
industry.

Net realized gain from sales of equity investments totaled 
$2,454,187 in 1995 mostly from the sales of Imagine 
Publishing, Inc. as discussed above, 3Com Corporation and 
Datalogix International, Inc.  In 1994, the realized gain of 
$425,431 primarily related to the sale of Alantec.

In 1995 and 1994, the Partnership realized losses from 
investments write-downs of $4,508,628 and $4,082,445, 
respectively.  Realized losses in 1995 primarily related to 
equity and secured notes receivable investments for portfolio 
companies in the medical and retail/consumer industries.  
Realized losses in 1994 primarily related to secured notes 
receivable to a portfolio company in the computers and 
computer equipment industry.

Secured notes receivable interest income increased to 
$1,479,613 in 1995 from $1,376,736 in 1994.  The increase was 
primarily due to interest payments received in 1995 from 
portfolio companies in the computer software and systems, 
telecommunications, and medical industries which had been on 
nonaccrual status.

Total operating expenses were $385,848 and $534,391 in 1995 
and 1994, respectively.  As explained in Note 3 to the 
financial statements, the Partnership may not pay or 
reimburse the General Partners for annual expenses that 
aggregate more than a certain percentage of total Limited 
Partner capital contributions.  The limitation is calculated 
over an operating year beginning May 1.  In 1995 and 1994, 
the General Partners absorbed $653,673 and $95,227, 
respectively.  Also discussed in Note 3, is the inclusion of 
$561,530 of additional administrative and investors services 
expenses.  Had such additional expenses been recorded in 
prior years, the operating expense limitation not been in 
effect, and the 1994 recoveries discussed in Note 3 to the 
financial statements not occurred, total operating expenses 
in 1995 and 1994 would have been $538,002 and $840,391, 
respectively.  The decrease in total operating expenses was 
primarily due to lower administrative and investor services, 
and lending operations and investment management expenses 
from lower overall portfolio activities.

There is no established source of market value information 
for the Partnership's portfolio of equity investments and 
secured notes receivable.  The value of the portfolio has 
been estimated by the Managing General Partner in the absence 
of readily ascertainable market values.  Although secured 
notes receivable are secured by specific assets of the 
borrowing company, due to the inherent uncertainty of 
valuation, estimated values may differ significantly from the 
values that would have been used had a ready market for the 
investment existed.  The difference could be material.

Given the inherent risk associated with the business of the 
Partnership, the future performance of portfolio company 
investments may significantly impact future operations.

1994 compared to 1993
- ---------------------

Net loss was $5,507,527 and $1,021,121 in 1994 and 1993, 
respectively.  The increase was primarily due to a $2,491,332 
decrease in the change in net unrealized fair value of equity 
investments, a $2,179,646 increase in realized losses from 
investment write-downs, and a $132,220 increase in other 
investment expenses.  These changes were partially offset by 
a $145,171 increase in total income and a $136,010 decrease 
in total operating expenses. 

The change in fair value of equity investments reflected a 
net decrease in the fair value of the Partnership's holdings.  
In 1994, the decrease of $2,281,481 was primarily due to a 
portfolio company in the medical industry.  In 1993, the 
increase was $209,851.  

In 1994 and 1993, the Partnership realized losses from 
investment write-downs of $4,082,445 and $1,902,799, 
respectively.  Realized losses in 1994 primarily related to 
secured notes receivable to a portfolio company in the 
computers and computer equipment industry.  Realized losses 
in 1993 primarily related to equity investments in a 
portfolio company in the retail/consumer products industry as 
well as the Partnership's loan portfolio for companies in the 
computers and computer equipment, and retail/consumer 
products industries.

During 1994, the Partnership recorded other investment 
expenses of $132,220 related to legal proceedings with a 
third party for a portfolio company in the retail/consumer 
products industry. The Managing General Partner is subject to 
indemnification for such costs pursuant to the Partnership 
Agreement.  See Note 9 to the financial statements for 
further details.  No such expenses were recorded in 1993.

Total income was $1,512,194 and $1,367,023 in 1994 and 1993, 
respectively.  The increase was primarily due to cash 
interest payments on a secured note receivable from a 
portfolio company in the computer software and systems 
industry which had been on nonaccrual status.  This increase 
was partially offset by a decrease in interest income due to 
the placement of secured notes receivable on nonaccrual 
status for portfolio companies in the medical and 
industrial/business automation industries.

Total operating expenses were $534,391 in 1994 compared to 
$670,401 in 1993. In 1994 and 1993, the General Partners 
absorbed operating expenses of $95,227 and $268,515, 
respectively.  As explained above, had the operating expense 
limitation not been in effect, had the 1994 recoveries not 
occurred, and had the additional expenses in 1995 been 
recorded in prior years, total operating expenses in 1994 and 
1993 would have been $840,391 and $1,001,198, respectively.  
The decrease in expenses was primarily due to lower lending 
operations and investment management, and administrative and 
investor services expenses as a result of lower overall 
portfolio activity.

Item 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
- ------   -------------------------------------------

The financial statements of the Registrant are set forth in 
Item 14.

Item 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
- ------   -----------------------------------------------------------
         AND FINANCIAL DISCLOSURE
         ------------------------

Registrant has reported no disagreements with its accountants 
on matters of accounting principles or practices or financial 
statement disclosure.

                               PART III

Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
- -------  --------------------------------------------------

As a partnership, the Registrant has no directors or 
executive officers.  Technology Funding Ltd., a California 
limited partnership ("TFL") and Technology Funding Inc., a 
California corporation ("TFI") and wholly-owned subsidiary of 
TFL, are the General Partners of the Partnership.  TFI is the 
Managing General Partner.  Information concerning the 
ownership of TFL and the business experience of the key 
officers of TFI and the partners of TFL is incorporated by 
reference from the sections entitled "Management of the 
Partnership - The General Partners" and "Management of the 
Partnership - Key Personnel of the Managing General Partners" 
in the Prospectus, which are incorporated herein by 
reference.  Changes in this information that have occurred 
since the date of the Prospectus are included in the 
Technology Funding Medical Partners I, L.P. Prospectus, as 
modified by Cumulative Supplement No. 4 dated January 4, 
1995, forming a part of the May 3, 1993 Pre-Effective 
Amendment No. 3 to the Form N-2 Registration Statement 
No. 33-54002 dated October 30, 1992 which is incorporated 
herein by reference.

Item 11. EXECUTIVE COMPENSATION
- -------  ----------------------

As a partnership, the Registrant has no officers or 
directors. In 1995, the Partnership incurred management fees 
of $201,640.  The management fees are designed to compensate 
the General Partners for General Partner Overhead incurred in 
performing management duties for the Partnership through 
December 31, 1995.  General Partner Overhead includes the 
General Partners' share of rent and utilities, and certain 
salaries and benefits paid by the General Partners in 
performing their obligations to the Partnership.

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND 
- -------  ---------------------------------------------------
         MANAGEMENT
         ----------

Not applicable.  No Limited Partner beneficially holds more 
than 5% of the aggregate number of Units held by all Limited 
Partners, and neither the General Partners nor any of their 
officers, directors or partners own any Units.  The General 
Partners control the affairs of the Partnership pursuant to 
the Partnership Agreement.

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
- -------  ----------------------------------------------

The Registrant, or its investee companies, have engaged in no 
transactions with the General Partners or their officers and 
partners other than as described above, in the notes to the 
financial statements, or in the Partnership Agreement.

                               PART IV

Item 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON 
- -------  -------------------------------------------------------
         FORM 8-K
         --------
(a)  List of Documents filed as part of this Annual Report 
on Form 10-K

(1)  Financial Statements - the following financial 
statements are filed as a part of this Report:

Independent Auditors' Report
Balance Sheets as of December 31, 1995
 and 1994
Statements of Operations for the years ended
 December 31, 1995, 1994 and 1993
Statements of Partners' Capital for 
 the years ended December 31, 1995, 1994
 and 1993
Statements of Cash Flows for the years
 ended December 31, 1995, 1994 and 1993
Notes to Financial Statements

(2)  Financial Statements Schedules

All schedules have been omitted because they are 
not applicable or the required information is 
included in the financial statements or the notes 
thereto.

(3)  Exhibits

Registrant's Amended and Restated Limited 
Partnership Agreement (incorporated by reference 
to Exhibit A to Registrant's Prospectus dated 
March 16, 1989 included in Registration Statement 
No. 33-26190 filed pursuant to Rule 424(b) of the 
General Rules and Regulations under the Securities 
Act of 1933).

(b)  Reports on Form 8-K

No reports on Form 8-K were filed by the Registrant 
during the year ended December 31, 1995.

(c)  Financial Data Schedule for the year ended and as of 
December 31, 1995 (Exhibit 27).
<PAGE>

                         INDEPENDENT AUDITORS' REPORT
                         ----------------------------



The Partners
Technology Funding Secured Investors III,
An Income And Growth Partnership, L.P.:


We have audited the accompanying balance sheets of Technology Funding 
Secured Investors III, An Income And Growth Partnership, L.P. (a 
California limited partnership) as of December 31, 1995 and 1994, and 
the related statements of operations, partners' capital, and cash 
flows for each of the years in the three-year period ended 
December 31, 1995.  These financial statements are the responsibility 
of the Partnership's management.  Our responsibility is to express an 
opinion on these financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing 
standards.  Those standards require that we plan and perform the audit 
to obtain reasonable assurance about whether the financial statements 
are free of material misstatement.  An audit includes examining, on a 
test basis, evidence supporting the amounts and disclosures in the 
financial statements.  Our procedures included confirmation of certain 
loans and securities owned, by correspondence with the individual 
borrowing and investee companies, and a physical examination of 
securities held by a safeguarding agent as of December 31, 1995 and 
1994.  An audit also includes assessing the accounting principles used 
and significant estimates made by management, as well as evaluating 
the overall financial statement presentation.  We believe that our 
audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present 
fairly, in all material respects, the financial position of Technology 
Funding Secured Investors III, An Income And Growth Partnership, L.P., 
as of December 31, 1995 and 1994, and the results of its operations 
and its cash flows for each of the years in the three-year period 
ended December 31, 1995 in conformity with generally accepted 
accounting principles.




San Francisco, California                        KPMG Peat Marwick LLP
March 22, 1996

<PAGE>

BALANCE SHEETS
- --------------

<TABLE>
<CAPTION>

                                                  December 31,
                                       -------------------------------
                                            1995               1994
                                            ----               ----
<S>                                    <C>                <C>
ASSETS

Investments:
 Secured notes receivable, net 
  (cost basis of $6,861,823 and 
  $12,385,060 in 1995 and 1994, 
  respectively)                       $ 2,833,823          8,569,060
 Equity investments (cost basis
  of $3,447,006 and $4,070,004 in
  1995 and 1994, respectively)          3,656,184          1,492,524
                                       ----------         ----------

     Total investments                  6,490,007         10,061,584

Cash and cash equivalents               7,046,622          1,921,850

Other assets                               50,200             75,113
                                       ----------         ----------

     Total                            $13,586,829         12,058,547
                                       ==========         ==========

LIABILITIES AND PARTNERS' CAPITAL

Accounts payable and accrued expenses $   349,663            100,005

Due to affiliated partnerships              1,930              1,054

Due to related parties                     36,737              7,376

Distributions payable                     391,777                 --

Other liabilities                          30,873             32,527
                                       ----------         ----------

     Total liabilities                    810,980            140,962

Commitments (Notes 3 and 9)

Partners' capital:
 Limited Partners
  (Units outstanding of 399,977 
  in both 1995 and 1994)               16,743,243         18,419,721
 General Partners                        (148,572)          (108,656)
 Net unrealized fair value (decrease)
  increase from cost:
  Secured notes receivable             (4,028,000)        (3,816,000)
  Equity investments                      209,178         (2,577,480)
                                       ----------         ----------

  Total partners' capital              12,775,849         11,917,585
                                       ----------         ----------

    Total                             $13,586,829         12,058,547
                                       ==========         ==========
</TABLE>

See accompanying notes to financial statements.

<PAGE>

STATEMENTS OF OPERATIONS 
- ------------------------


<TABLE>
<CAPTION>
                                    For the Years Ended December 31,
                                -------------------------------------
                                    1995        1994         1993
                                    ----        ----         ----
<S>                            <C>           <C>           <C>
          
Income:
 Secured notes receivable
  interest                     $ 1,479,613    1,376,736     1,185,647
 Short-term investment interest    102,875      118,585       147,704
 Other income                        6,858       16,873        33,672
                                 ---------    ---------     ---------
  Total income                   1,589,346    1,512,194     1,367,023

Costs and expenses:
 Management fees                   201,640      272,615       374,130
 Amortization of organizational
  costs                                 --        3,000         9,000
 Other investment expenses         272,034      132,220            --
 Operating expenses:
  Lending operations and
   investment management           155,642      220,552       428,277
  Administrative and investor
   services                        750,214      280,705       326,591
  Computer services                 65,695       77,113        94,518
  Professional fees                 67,970       51,248        89,530
  Expenses absorbed by
   General Partners               (653,673)     (95,227)     (268,515)
                                 ---------    ---------     ---------

   Total operating expenses        385,848      534,391       670,401
                                 ---------    ---------     ---------

 Total costs and expenses          859,522      942,226     1,053,531
                                 ---------    ---------     ---------

Net operating income               729,824      569,968       313,492

 Net realized gain from sales
  of equity investments          2,454,187      425,431       476,335
 Realized losses from
  investment write-downs        (4,508,628)  (4,082,445)   (1,902,799)
                                 ---------    ---------     ---------

Net realized loss               (1,324,617)  (3,087,046)   (1,112,972)

 Change in net unrealized 
  fair value:
   Equity investments            2,786,658   (2,281,481)      209,851
   Secured notes receivable       (212,000)    (139,000)     (118,000)
                                 ---------    ---------     ---------

Net income (loss)              $ 1,250,041   (5,507,527)   (1,021,121)
                                 =========    =========     =========

Net realized loss
   per Unit                    $        (3)          (8)           (3)
                                 =========    =========     =========
</TABLE>
See accompanying notes to financial statements.



<PAGE>

STATEMENTS OF PARTNERS' CAPITAL 
- ------------------------------


<TABLE>
<CAPTION>
For the years ended December 31, 1995, 1994 and 1993:

                                                        Net Unrealized Fair Value
                                                      Increase (Decrease) From Cost
                                                      -----------------------------
                                Limited      General     Equity     Secured Notes
                               Partners     Partners   Investments   Receivable    Total
                               --------     --------   -----------   ----------    -----
<S>                           <C>            <C>       <C>          <C>         <C>

Partners' capital,
 December 31, 1992            $25,567,122    (36,461)    (505,850)  (3,559,000) 21,465,811

Distributions                  (2,420,957)   (24,454)          --           --  (2,445,411)

Net realized loss              (1,101,842)   (11,130)          --           --  (1,112,972)

Change in net unrealized fair 
 value:
  Equity investments                   --         --      209,851           --     209,851
  Secured notes receivable             --         --           --     (118,000)   (118,000)
                               ----------    -------    ---------    ---------  ----------

Partners' capital,
 December 31, 1993             22,044,323    (72,045)    (295,999)  (3,677,000) 17,999,279

Distributions                    (568,425)    (5,742)          --           --    (574,167)

Net realized loss              (3,056,177)   (30,869)          --           --  (3,087,046)

Change in net unrealized fair 
 value:
  Equity investments                   --         --   (2,281,481)          --  (2,281,481)
  Secured notes receivable             --         --           --     (139,000)   (139,000)
                               ----------    -------    ---------    ---------  ----------

Partners' capital,
 December 31, 1994             18,419,721   (108,656)  (2,577,480)  (3,816,000) 11,917,585
                                                                                          

Distributions                    (365,107)   (26,670)                             (391,777)

Net realized loss              (1,311,371)   (13,246)          --           --  (1,324,617)

Change in net unrealized fair 
 value:
  Equity investments                   --         --    2,786,658           --   2,786,658
  Secured notes receivable             --         --           --     (212,000)   (212,000)
                               ----------    -------    ---------    ---------  ----------

Partners' capital,
 December 31, 1995            $16,743,243   (148,572)     209,178   (4,028,000) 12,775,849
                               ==========    =======    =========    =========  ==========

</TABLE>
See accompanying notes to financial statements.



<PAGE>

STATEMENTS OF CASH FLOWS
- ------------------------

<TABLE>
<CAPTION>
                                   For the Years Ended December 31,
                                  ------------------------------------
                                       1995       1994         1993
                                       ----       ----         ----

<S>                               <C>          <C>         <C>
Cash flows from operating
  activities:
 Interest received                $ 1,590,420     920,099   1,048,331
 Other income received                  6,858      16,873      33,672
 Cash paid to vendors                (365,059)   (504,228)   (404,293)
 Cash paid to related parties        (429,369)   (688,844) (1,115,010)
 Cash received from/(paid to)
  affiliated partnerships                 876      40,179     (55,985)
 Reimbursement of collection
  expenses received from a 
  portfolio company                        --     187,441          --
                                    ---------   ---------   ---------
    Net cash provided (used)
     by operating activities          803,726     (28,480)   (493,285)
                                    ---------   ---------   ---------

Cash flows from investing
 activities:
 Secured notes receivable issued   (1,216,335) (4,075,046) (9,089,745)
 Repayments of secured notes 
  receivable                        2,170,864   3,147,801   8,133,335
 Proceeds from sales of 
  equity investments                3,366,988     430,181   1,852,576
 Purchase of equity investments          (471)    (48,206)    (21,101)
 Purchase of other investments             --          --    (650,000)
                                    ---------   ---------  ----------
Net cash provided (used) by
 investing activities               4,321,046    (545,270)     225,065
                                    ---------   ---------   ----------

Cash flows from financing 
  activities:
 Distributions to Limited and 
  General Partners                         --    (574,167) (3,265,499)
                                    ---------   ---------   ---------

  Net cash used by financing
   activities                              --    (574,167) (3,265,499)
                                    ---------   ---------   ---------

Net increase (decrease) in cash
 and cash equivalents               5,124,772  (1,147,917) (3,533,719)

Cash and cash equivalents at 
 beginning of year                  1,921,850   3,069,767   6,603,486
                                    ---------   ---------   ---------

Cash and cash equivalents at 
 end of year                      $ 7,046,622   1,921,850   3,069,767
                                    =========   =========   =========

</TABLE>
See accompanying notes to financial statements.

<PAGE>

STATEMENTS OF CASH FLOWS (continued)
- -----------------------------------
<TABLE>
<CAPTION>
                                      For the Years Ended December 31,
                                   -----------------------------------
                                     1995          1994        1993
                                     ----          ----        ----
<S>                               <C>          <C>         <C>
Reconciliation of net income
 (loss) to net cash provided 
 (used) by operating activities:

Net income (loss)                 $ 1,250,041  (5,507,527) (1,021,121)

Adjustments to reconcile net 
 income (loss) to net cash
 provided (used) by operating
 activities:
 Amortization of organizational
  costs                                    --       3,000       9,000
 Amortization of discount 
   on secured notes receivable        (18,163)    (12,110)    (72,082)
 Net realized gain from sales of
  equity investments               (2,454,187)   (425,431)   (476,335)
 Realized losses from investment
  write-downs                       4,508,628   4,082,445   1,902,799
 Change in net unrealized 
  fair value:
   Equity investments              (2,786,658)  2,281,481    (209,851)
   Secured notes receivable           212,000     139,000     118,000

Changes in:
  Accrued interest on secured and
   convertible notes receivable        16,095    (563,112)   (212,938)
  Accounts payable and accrued
   expenses                            12,474     (21,134)    (29,114)
  Due to/from related parties          29,361      16,144    (459,825)
  Due to/from affiliated 
   partnerships                           876      40,179     (55,985)
  Other assets                         24,913     (73,283)      9,322 
  Other liabilities                    (1,654)     11,868       4,845
  Other, net                           10,000          --          --
                                    ---------   ---------   ---------

Net cash provided (used)
  by operating activities         $   803,726     (28,480)   (493,285)
                                   ==========   =========   =========

Non-cash investing activities:

Additions to equity investments   $   142,432     100,556       6,667
                                   ==========   =========   =========

Conversion of secured notes
 receivable and interest to
 equity investments               $ 2,919,541   2,270,450   2,374,746
                                   ==========   =========   =========

Conversion of other investments
 to secured notes receivable      $        --     650,000          --
                                   ==========   =========   =========

Non-cash exercise of warrants     $   113,933      (1,122)         --
                                   ==========   =========   =========

</TABLE>
See accompanying notes to financial statements.

<PAGE>

NOTES TO FINANCIAL STATEMENTS
- -----------------------------

1.     Summary of Significant Accounting Policies
       ------------------------------------------

Organization
- ------------

Technology Funding Secured Investors III, An Income and Growth 
Partnership, L.P., (the "Partnership") is a limited partnership 
organized under the laws of the State of California on 
December 9, 1988.  From December 9, 1988 through March 15, 1989, the 
Partnership was inactive.  The registration statement of the 
Partnership was filed with the Securities and Exchange Commission and 
became effective on March 16, 1989.  The purpose of the Partnership is 
to provide loans secured by equipment and other assets to new and 
developing companies and to acquire, hold, sell, trade, exchange or 
otherwise dispose of warrants and/or capital stock acquired by the 
Partnership in conjunction with these loans.  The General Partners are 
Technology Funding Ltd. ("TFL") and Technology Funding Inc. ("TFI"), a 
wholly-owned subsidiary of TFL.  TFI is the Managing General Partner.  
A wholly-owned subsidiary of TFI, Technology Funding Securities 
Corporation ("TFSC"), was the dealer-manager for the offering.

The Partnership commenced selling units of limited partnership 
interest ("Units") on April 13, 1989.  On May 2, 1989 the minimum 
number of Units required to commence Partnership operations (12,000) 
had been sold.  The Partnership completed the offering of the Units of 
limited partnership interest on March 15, 1991.  The offering 
terminated with 399,977 Units sold.  The Partnership Agreement 
provides that the Partnership will continue until December 31, 1998, 
unless further extended for up to two additional two-year periods from 
such date if the General Partners so determine or the Partnership may 
be dissolved sooner.

Preparation of Financial Statements and Use of Estimates
- --------------------------------------------------------

These financial statements have been prepared on the accrual basis of 
accounting in accordance with generally accepted accounting 
principles.  This requires management to make estimates and 
assumptions that affect the reported amounts of assets and liabilities 
and disclosure of contingent assets and liabilities at the date of the 
financial statements and the reported amounts of revenues and expenses 
during the reporting period.  Actual results could differ from those 
estimates.

The financial statements include non-marketable investments of 
$6,259,013 and $9,844,904 (49% and 83% of partners' capital) as of 
December 31, 1995 and 1994, respectively, whose values have been 
estimated by the Managing General Partner in the absence of readily 
ascertainable market values.  Because of the inherent uncertainty of 
valuation, those estimated values may differ significantly from the 
values that would have been used had a ready market for investments 
existed, and the differences could be material.  In addition, for 
certain publicly traded investments that may not be marketable due to 
selling restrictions, the Managing General Partner has applied an 
illiquidity discount of 25% in determining fair value as mentioned 
below.

Cash and Cash Equivalents
- -------------------------

Cash and cash equivalents are principally comprised of cash invested 
in demand accounts, money market instruments and commercial paper and 
are stated at cost plus accrued interest.  The Partnership considers 
all money market and short-term investments with an original maturity 
of three months or less to be cash equivalents.

Provision for Income Taxes
- --------------------------

No provision for income taxes has been made by the Partnership, as the 
Partnership is not directly subject to taxation.  The partners are to 
report their respective shares of Partnership income or loss on their 
individual tax returns.

The accompanying financial statements are prepared using generally 
accepted accounting principles which may not equate to tax accounting. 
The Partnership's total tax basis in investments was higher than the 
reported total cost basis of $10,308,829 by $3,068,406.

Net Realized Income (Loss) Per Unit
- -----------------------------------

Net realized income (loss) per Unit is calculated by dividing the 
number of Units outstanding (399,977) at December 31, 1995, 1994 and 
1993 into total net realized income (loss) allocated to the Limited 
Partners.  The General Partners contributed an amount equal to 0.1% of 
total Limited Partner capital contributions and did not receive any 
Partnership Units.

Investments:
- -----------

The Partnership's method of accounting for investments, in accordance 
with generally accepted accounting principles, is the fair value basis 
used for investment companies.  The fair value of Partnership 
investments is their initial cost basis with changes as noted below:

     Secured Notes Receivable, Net
     -----------------------------

The secured notes receivable portfolio includes accrued interest less 
the discount related to warrants and the allowance for loan losses.  
The portfolio approximates fair value through inclusion of an 
allowance for loan losses.  Allowance for loan losses is reviewed 
quarterly by the Managing General Partner and is adjusted to a level 
deemed adequate to cover possible losses inherent in notes and 
unfunded commitments.  Notes receivable are placed on nonaccrual 
status when, in the opinion of the Managing General Partner, the 
future collectibility of interest or principal is in doubt.

In conjunction with certain secured notes issued, the Partnership 
receives warrants to purchase certain shares of capital stock of the 
borrowing company.  The cost basis of the warrants and the resulting 
discount has been estimated by the Managing General Partner to be 1% 
of the principal balance of the original notes made to the borrowing 
company.  The discount is amortized to interest income on a straight-
line basis over the term of the loan.  These warrants are included in 
the equity investment portfolio.

Nonrefundable fees received in connection with loan fundings are 
deferred and amortized to interest income over the contractual life of 
the loan using the effective interest method or the straight-line 
method if it is not materially different.  Direct loan origination 
costs mainly consist of third-party costs and generally are reimbursed 
by portfolio companies.

     Equity Investments
     ------------------

The fair value for publicly-traded equity investments (marketable 
equity securities) is based upon the five-day average closing sales 
price or bid/ask price that is available on a national securities 
exchange or over-the-counter market. Certain publicly-traded equity 
investments may not be marketable due to selling restrictions.  For 
publicly-traded equity investments with selling restrictions, an 
illiquidity discount of 25% is applied when determining the fair 
value.  Sales of equity investments are recorded on the trade date.  
The basis on which cost is determined in computing realized gains or 
losses is generally specific identification.

Other equity investments, which are not publicly traded, are generally 
valued utilizing pricing obtained from the most recent round of third 
party financings.  Valuation is determined quarterly by the Managing 
General Partner.  Included in equity investments are convertible and 
subordinated notes receivable as repayment of these notes generally 
occur through conversion into equity investments.

Equity investments with temporary changes in fair value result in 
increases or decreases to the unrealized fair value of equity 
investments.  The cost basis does not change.  In the case of an other 
than temporary decline in value below cost basis, an appropriate 
reduction in the cost basis is recognized as a realized loss.  
Adjustments to fair value basis are reflected as "Change in net 
unrealized fair value of equity investments."  Cost basis adjustments 
are reflected as "Realized losses from investment write-downs" on the 
Statements of Operations.

Non-cash Exercise of Warrants
- -----------------------------

Periodically, the Partnership may acquire stock through the non-cash 
exercise of warrants.  During 1995 and 1994, realized gains (losses) 
resulting from the non-cash exercise of warrants totaled $113,933 and 
$(1,122), respectively.  No such event occurred in 1993.  These 
amounts are included in net realized gain from sales of equity 
investments.

Distributions
- -------------

Distributions made to the Limited Partners are made among such 
partners in proportion to their respective capital accounts to the 
total of all capital accounts of the group.  Unnegotiated distribution 
checks, if any, after a reasonable amount of time, are recorded as 
other liabilities on the Balance Sheets.


2.     Change in Net Unrealized Fair Value of Equity Investments
       ---------------------------------------------------------

In accordance with the accounting policy as stated in Note 1, the 
Statements of Operations include a line item entitled "Change in net 
unrealized fair value of equity investments."  The table below 
discloses details of the changes:

<TABLE>
<CAPTION>

                                 For the Years Ended December 31,
                            ------------------------------------------
                                  1995         1994          1993
                                  ----         ----          ----
<S>                           <C>            <C>         <C>

(Decrease) increase in fair
 value from cost of
 marketable equity securities $   (17,136)     (9,163)       37,000
Increase (decrease) in fair
 value from cost of non-
 marketable equity securities     226,314  (2,568,317)     (332,999)
                                ---------   ---------       -------
Net unrealized fair value
 increase (decrease) from
 cost at end of year              209,178  (2,577,480)     (295,999)
Net unrealized fair value
 decrease from cost
 at beginning of year          (2,577,480)   (295,999)     (505,850)
                                ---------   ---------       -------
Change in net unrealized 
 fair value of equity
 investments                  $ 2,786,658  (2,281,481)      209,851
                                =========   =========       =======

</TABLE>


3.     Related Party Transactions
       --------------------------

Related party costs are included in costs and expenses shown on the 
Statements of Operations.  For the years ended December 31, 1995, 1994 
and 1993, related party costs were as follows:

<TABLE>
<CAPTION>

                                 1995           1994           1993
                                 ----           ----           ----
<S>                           <C>             <C>            <C>

Management fees               $201,640        272,615        374,130
Amortization of
 organizational costs               --          3,000          9,000
Reimbursable operating
 expenses:
  Lending operations and
   investment management       128,757        234,262        229,194
  Administrative and 
   investor services           716,311        216,225        225,858
  Computer services             65,695         77,113         94,518
  Expenses absorbed by
   General Partners           (653,673)       (95,227)      (268,515)

</TABLE>
Management fees compensate the General Partners solely for General 
Partner Overhead (as defined in the Partnership Agreement) incurred in 
supervising the operation, management, and progress of Partnership 
loans to borrowing companies and its portfolio of warrants and capital 
stock of borrowing companies, as well as for the general 
administration of the Partnership.  Management fees are equal to the 
greater of one-half of one percent of the Partnership's assets under 
management or $2,500 each quarter. 

Management fees are accrued and are only paid to the extent that the 
aggregate amount of all proceeds (including those from warrants 
exercised without cash) received by the Partnership from the sale or 
other disposition of borrowing company equity securities plus the 
aggregate fair market value of any equity interest distributed to the 
partners exceeds the total management fees payable.  All management 
fees had been paid at December 31, 1995 and 1994.

The Partnership reimburses the Managing General Partner and affiliates 
for operating expenses incurred in connection with the business of the 
Partnership.  Reimbursable operating expenses include expenses (other 
than Organization and Offering and General Partner Overhead) such as 
investment operations, administrative, and investor services and 
computer services.  During late 1995, operating cost allocations to 
the Partnership were reevaluated.  The Managing General Partner 
determined that it had not fully recovered allocable overhead as 
permitted by the Partnership Agreement.  As a result, the Partnership 
was allocated additional administrative and investor services costs of 
$561,530, which were not previously recognized by the Partnership; 
however, $523,886 of this amount was absorbed by the General Partners.  
The $561,530 consisted of $60,011, $58,585, $62,282, and $380,652 
related to 1995, 1994, 1993, and prior years, respectively.

As discussed in the Partnership Agreement, the Partnership may not pay 
or reimburse the General Partners for expenses that aggregate more 
than 2% of total Limited Partner capital contributions in any of the 
first five years of Partnership operations, and 1% thereafter.  For 
purposes of this limitation, the Partnership's operating year begins 
each May 1st.  Beginning May 1, 1994, the limitation was calculated 
using 1% of total Limited Partner capital contributions.  Operating 
costs of $653,673, $95,227, and $268,515 for the years ended 
December 31, 1995, 1994 and 1993, respectively, were absorbed by the 
General Partners. 

During 1994, the Partnership was reimbursed $187,441 by a portfolio 
company for legal, consulting, and other external costs incurred in 
the defense of the Partnership's secured note rights through 
bankruptcy court.  Of the amount reimbursed, approximately $130,000 
was incurred in periods prior to 1994 during which the operating 
expense limitation applied.  Similarly, another reimbursement of 
approximately $28,000 was received during 1994, of which approximately 
$24,000 was expensed during 1993 when the operating expense limitation 
applied.  The $130,000 and $24,000 recoveries were recorded as 
reductions to lending operations and investment management expense, 
and the amount absorbed by General Partners was reduced by equivalent 
amounts.

Had the operating expense limitation not been in effect and the above 
additional charge been recorded in prior years, and had the above 
reimbursement not been received, total operating expenses would have 
been $538,002, $840,391, and $1,001,198 for 1995, 1994 and 1993, 
respectively.  At December 31, 1995 and 1994, due to related parties 
totaled $36,737 and $7,376, respectively.

Under the terms of a computer support agreement, the Partnership 
recognized charges from Technology Administrative Management, a 
division of TFL, for its share of computer support costs.  These 
amounts are included in computer services expense.

Within the normal course of business, the Partnership participates 
with affiliated partnerships in secured notes receivable issued to 
non-affiliated borrowing companies by affiliated partnerships which 
are also managed by the General Partners.  The Partnership may also 
reparticipate such secured notes receivable amongst affiliated 
partnerships to meet business needs.  At December 31, 1995 and 1994, 
due to affiliated partnerships on such participations were $1,930 and 
$1,054, respectively.  These amounts were paid to such affiliated 
partnerships by the Partnership immediately following the respective 
year ends.

In order to increase the future investment returns from several 
portfolio companies, the Partnership has contracted directly with 
Affiliates of the General Partners or the General Partners as provided 
in Article 3 sections 3.02(d) and 3.08.  These agreements generally 
provide for the Partnership to make current payment of the direct 
expenses of the Affiliate or the General Partners related to such 
recovery efforts as well as a performance incentive payment based on 
the amount of incremental recovery less expenses previously paid, 
which expenses will be returned to the Partnership from recoveries.  
The General Partners have agreed to waive any profit interest payable 
pursuant to Article 8 Section 8.01(d) attributable to any recoveries 
from the portfolio companies subject to these separate written 
agreements.  These agreements are subject to review by legal counsel 
for the Partnership and may be modified to assure conformity with the 
terms of the Partnership's Amended and Restated Limited Partnership 
Agreement.  Consistent with note participations as discussed above, 
the agreements provide for a pro-rata payment of expenses and 
incentive payments and a pro-rata participation in the results of 
recovery efforts.

In 1995 and 1994, TFL had a sublease rental agreement with a 
Partnership portfolio company in the computers and computer equipment 
industry.  The terms of this agreement were similar to those which 
would apply to an unrelated party.  This agreement was terminated in 
the fourth quarter of 1995.

4.     Distributions Payable
       ---------------------

In early 1995, the Partnership ended its mandatory reinvestment 
period, as defined in the Partnership Agreement, and entered its 
liquidation stage.  In December 1995, distributions totaling $391,777 
were declared and will be paid in March 1996.  Future distributions 
will be dependent upon loan repayments from borrowing companies and 
available cash, and are expected to fluctuate.

5.     Allocation of Profits and Losses
       --------------------------------

Net realized profit and loss of the Partnership are allocated based on 
the beginning of year partners' capital balances as follows:

     (a)  Profits:

(i)  first, to those partners with deficit capital account 
balances until deficits have been eliminated;

(ii) second, to the partners as necessary to offset the net 
realized loss previously allocated under (b)(ii) below 
and sales commissions;

(iii)third, 99% to the Limited Partners and 1% to the 
General Partners until the Limited Partners have been 
allocated cumulative net realized profit or other 
income which would, if distributed, result in a 
cumulative, compounded annual return to the Limited 
Partners of 8% of their adjusted capital contributions;

(iv) fourth, 75% to the Limited Partners as a group in 
proportion to the number of Units held, 5% to the 
Limited Partners in proportion to the Unit months of 
each Limited Partner as discussed below, and 20% to the 
General Partners.  Unit months are the number of half 
months a Unit would be outstanding if held from the 
date the original holder of such Unit was deemed 
admitted into the Partnership until the termination of 
the offering of Units.

Allocations to the Limited Partners are made in the 
proportion that the number of Units held by each 
Limited Partner multiplied by the number of Unit months 
for those Units represents of the total number of Units 
multiplied by the total number of Unit months of all 
Units.  

In no event are the General Partners allocated less 
than 1% of the net realized profit of the Partnership.

     (b)  Losses:

(i)  first, to the partners as necessary to offset the net 
realized profit previously allocated to the partners 
under (a)(iv) above; then

(ii) 99% to the Limited Partners and 1% to the General 
Partners.

Losses in excess of Limited Partner capital accounts will 
be allocated to the General Partners.

6.     Equity Investments
       ------------------

At December 31, 1995 and 1994, equity investments consisted of:



<TABLE>
<CAPTION>

                                                  December 31, 1995          December 31, 1994
                                                  -----------------          -----------------
                    Investment                     Cost        Fair          Cost         Fair
Industry/Company       Date      Position          Basis       Value         Basis       Value
- ----------------    ----------   --------          -----       -----         -----       -----
<S>                 <C>          <C>               <C>         <C>         <C>         <C>
WARRANTS:

Biotechnology
- -------------
Biocircuits         01/91        5,000 Common
 Corporation                     shares at $8.00;
                                 expiring 01/96    $      0         600           0           0
Hybridon, Inc.      03/91        7,142 Common
                                 shares at $3.50;
                                 expiring 03/97       2,500      32,139       2,500      32,139

Computers and Computer Equipment
- --------------------------------
MARCorp             05/92        1,595,745 Series B
                                 Preferred shares
                                 at $1.00; expiring
                                 05/97                   --          --           0           0
MARCorp             06/93        566,667 Series B
                                 Preferred shares 
                                 at $.75; expiring
                                 06/98                   --          --           0           0
MARCorp             08/93        500,000 Series B
                                 Preferred shares at
                                 $.75; expiring 08/98    --          --           0           0
MARCorp.            03/94        125,000 Series B 
                                 Preferred shares at
                                 $.75; expiring 03/99    --          --           0           0
Pinnacle Systems,   05/90        2,083 Common
 Inc.                            shares at $8.00; 
                                 exercised 02/95         --          --       2,500      14,164

Computer Software and Systems
- -----------------------------
Datalogix           01/92        35,575 Common
 International,                  shares at $1.87;
 Inc.                            exercised 06/95         --          --      20,000      20,000
Molecular           10/90        6,111 Common
 Simulations, Inc.               shares at
                                 $18.00;
                                 expired 10/95           --          --           0           0
Wasatch Education   04/93        705,971 Common
 Systems                         shares at $.50;
 Corporation                     expiring 04/98          --          --           0           0
Wasatch Education   07/93        33,333 Common
 Systems                         shares at $.50;
 Corporation                     expiring 07/98          --          --       6,667           0
Wasatch Education   02/94        366,667 Common
 Systems                         shares at $.50;
 Corporation                     expiring 02/99          --          --       3,333           0
Wasatch Education   06/95        1,159,546 Common
 Systems                         shares at $0.50;
 Corporation                     expiring 06/00      10,000     217,415          --          --

Industrial/Business Automation
- ------------------------------
Cyclean, Inc.       03/91        44,589 Common
                                 shares at $3.10;
                                 expiring 04/01           0           0       7,500           0
Cyclean, Inc.       07/92        20,967 Common
                                 shares at $3.10;
                                 expiring 07/97           0           0       2,500           0
Cyclean, Inc.       07/92        53,130 Common
                                 shares at $3.10;
                                 expiring 07/02           0           0       1,176           0
Cyclean, Inc.       09/94        8,065 Common
                                 shares at $3.10;
                                 expiring 03/99           0           0           0           0
Cyclean, Inc.       09/94        9,464 Common
                                 shares at $4.00;
                                 expiring 03/99           0           0           0           0
Cyclean, Inc.       01/95        9,750 Common
                                 shares at $4.00;
                                 expiring 01/00           0           0          --          --
ElectroScan         12/91        22,177 Common
 Corporation                     shares at $3.10;
                                 expiring 12/96           0           0           0           0

Medical
- -------
Loredan             05/92        62,500 Common
 BioMedical,                     shares at $.60;
 Inc.                            expiring 05/97           0           0           0           0
Loredan             12/92        166,667 Common
 BioMedical,                     shares at $.30;
 Inc.                            expiring 12/97           0           0           0           0
Microgon, Inc.      10/90        125,000 Common
                                 shares at $.60;
                                 expired 10/95           --          --           0           0
Microgon, Inc.      09/91        29,167 Common
                                 shares at $.60;
                                 expiring 09/96          --          --           0           0
Microgon, Inc.      06/92        125,000 Common
                                 shares at $.60;
                                 expiring 06/97          --          --           0           0

Telecommunications
- ------------------
Integrated Network  06/91        5,882 Common
 Corporation                     shares at $17.00;
                                 expiring 06/96      10,000           0      20,000     100,002
Primary Access      10/90        30,000 Common
 Corporation                     shares at $2.25;
                                 exercised 06/95         --          --       6,000       6,000
                                                     ------     -------     -------     -------

Total warrants                                       22,500     250,154      72,176     172,305
                                                     ------     -------     -------     -------

STOCKS:

Computers and Computer Equipment
- --------------------------------
MTI Technology      04/94        20,927 Common
 Corporation                     shares             188,343      43,947     188,343      74,563
Wasatch Education   06/95        2,908,450
 Systems                         Series C
 Corporation                     Preferred
                                 shares           2,908,450   2,908,450          --          --

Industrial/Business Automation
- ------------------------------
Cyclean, Inc.       09/94        36,042 Series D
                                 Preferred
                                 shares             100,556     100,556     100,556     100,556
Cyclean, Inc.       01/95        51,051 Series D
                                 Preferred shares   142,432     142,432          --          --
Cyclean of          03/95        Class A LLC Unit -
 Los Angeles, LLC                44% ownership       11,091      11,091          --          --

Medical
- -------
Allegiant           08/94        31,500 Common
 Physicians                      shares       
 Services, Inc.                                      11,250      52,500      35,000     127,953
Allegiant           11/95        17,500 Common
 Physicians                      shares       
 Services, Inc.                                       6,250      29,167          --          --
Resonex Holding     02/94        22,804 Common
 Corporation                     shares                   0           0   1,682,507           0

Microelectronics
- ----------------
Celeritek, Inc.     05/94        6,785 Common
                                 shares              36,087      52,563      36,087      36,087

Retail/Consumer Products
- ------------------------
Imagine Publishing, 03/92        200,000 Common
 Inc. (formerly                  shares
 GP Publications,                                  
 Inc.)                                                   --          --     200,000     200,000
Imagine Publishing, 06/93        435,310 Common
 Inc. (formerly                  shares
 GP Publications,                               
 Inc.)                                                   --          --     435,310     435,310
S-TRON              05/93        Subordinated
                                 note (1), $390,000 
                                 principal amount         0           0     392,015     130,316
S-TRON              05/93        390,000 Common
                                 shares                   0           0           0           0
S-TRON              05/93        897,000 
                                 Series 1
                                 Preferred shares         0           0     295,740           0
S-TRON              05/93        2,753,356 
                                 Series 2
                                 Preferred shares         0           0     618,387     201,551

Telecommunications
- ------------------
All Post, Inc.      10/94        17,574 Common
                                 shares              13,883      13,883      13,883      13,883
3Com Corporation    06/95        1,160 Common
                                 shares in
                                 escrow               6,164      51,441          --          --
                                                  ---------   ---------   ---------   ---------

  Total stocks                                    3,424,506   3,406,030   3,997,828   1,320,219
                                                  ---------   ---------   ---------   ---------

  Total equity investments                       $3,447,006   3,656,184   4,070,004   1,492,524
                                                  =========   =========   =========   =========


- --  No investment held at end of period.
0   Investment active with a carrying value or fair value of zero.
(1) Subordinated note includes accrued interest.  The subordinated note interest rate was 6%.


</TABLE>




Marketable Equity Securities
- ----------------------------

At December 31, 1995 and 1994, marketable equity securities had 
aggregate costs of $248,130 and $225,843, respectively, and aggregate 
market values of $230,994 and $216,680, respectively.  The net 
unrealized loss at December 31, 1995 and 1994 included gross gains of 
$127,260 and $104,617, respectively.

Allegiant Physician Services, Inc.
- ----------------------------------

In August 1995, the Partnership exercised its option to sell half of 
its common stock holdings to the company for $52,500 and realized a 
gain of $35,000.  In November 1995, the Partnership received an 
additional 17,500 common shares from the company as settlement for the 
company's failure to register the Partnership's common stock holdings 
by March 1995 as stipulated in a 1994 agreement.  The Partnership has 
options to sell all shares to the company at a later date.  An 
unrealized fair value of $81,667 was recorded to reflect the option 
value which is greater than the market value for the Partnership's 
unrestricted common shares at December 31, 1995.

Celeritek , Inc.
- ----------------

In December 1995, Celeritek, Inc. completed its IPO after effecting a 
common stock 3-for-2 split.  The Partnership sold 141 of its post-
split common shares acquired in April 1995 into the IPO for proceeds 
of $986 and realized a gain of $515.  The Partnership recorded a 
$16,476 increase in fair value to reflect the market value of $52,563 
for its remaining shares at December 31, 1995.  The market value 
reflects a 25% discount for certain lockup restrictions.

Cyclean, Inc./Cyclean of Los Angeles, LLC
- -----------------------------------------

In January 1995, the Partnership obtained the right to receive 51,051 
Series D Preferred shares with a twelve month vesting schedule in 
exchange for a one year maturity date extension of secured notes 
receivable.  At December 31, 1995, all 51,051 shares were fully vested 
with a recorded cost basis and fair value of $142,432.

In March 1995, Cyclean, Inc. ("Cyclean") formed Cyclean of Los 
Angeles, LLC ("Cyclean LLC") and contributed certain assets and 
contracts to the new entity.  Cyclean LLC is completing a new round of 
financing through the offering of Class A LLC Units.  As a result of 
this transaction, one of the Partnership's secured notes receivable 
was transferred from Cyclean to Cyclean LLC with modified terms; 
Cyclean has guaranteed note repayments.  The Partnership received a 
participated percentage of one Class A LLC Unit in exchange for 
certain interest payments and late charges totaling $11,091.  The 
Partnership is also entitled to royalty payments and additional Series 
D Preferred shares based on the total proceeds raised from the Cyclean 
LLC offering, which is expected to be completed by early 1996.

In December 1995, all warrant cost bases totaling $11,176 were written 
off as these warrants are expected to be canceled at the close of the 
next financing round.

Datalogix International, Inc.
- -----------------------------

In June 1995, Datalogix International, Inc. completed its IPO.  The 
Partnership exercised its warrant without cash and sold all of its 
resulting common shares in the company for total proceeds of $228,812 
and a realized gain of $208,812.

Imagine Publishing, Inc. (formerly GP Publications, Inc.)
- ---------------------------------------------------------

In December 1995, the Partnership sold its remaining 50% investment of 
635,310 common shares to a third party for net proceeds of $2,450,316 
resulting in a realized gain of $1,815,006.  The first half of the 
investment was sold to the same buyer in October 1993 for net proceeds 
of $572,917.

Integrated Network Corporation
- ------------------------------

During June 1995, the Partnership exercised its option to sell half of 
its warrant holdings to the company for $100,000 and realized warrant 
income of $90,000, which was included in "secured notes receivable 
interest income" on the Statements of Operations.  The Partnership 
does not have this option for its remaining warrant.

Pinnacle Systems, Inc.
- ----------------------

In February 1995, the Partnership exercised its warrant without cash 
and received 1,971 common shares.  In May 1995, the Partnership sold 
the common shares for total proceeds of $37,449 and realized a gain of 
$34,949.

Primary Access Corporation/3Com Corporation
- -------------------------------------------

In June 1995, Primary Access Corporation ("Primary Access") was 
acquired by 3Com Corporation ("3Com"), a public company.  Immediately 
prior to the acquisition, the Partnership exercised its Primary Access 
common warrant holdings without cash and received 25,205 shares of 
Primary Access common stock with a cost basis of $61,638, which 
reflects a realized gain of $55,638 and a warrant cost basis of 
$6,000.  Upon the acquisition, these shares were then exchanged for 
5,802 3Com common shares, of which 5,222 shares were sold for total 
proceeds of $359,741 and a realized gain of $304,267 in July 1995.  
The remaining 580 shares, which became 1,160 shares after a 2-for-1 
stock split in August 1995, are held in an escrow account until March 
21, 1996 to indemnify 3Com for any loss it may incur as a result of 
any contractual breach of the merger agreement by Primary Access.  The 
Partnership recorded an increase in the change in fair value of 
$45,277 to reflect the market value at December 31, 1995 for these 
unrestricted shares.

Resonex Holding Corporation
- ---------------------------

Resonex Holding Corporation has licensed certain technologies and is 
currently obtaining additional bids from potential licensees.  The 
company may wind down its operations by mid-1996.  Based on the 
opinion of the Managing General Partner, there has been an other than 
temporary decline in Partnership's investment value and accordingly, 
the common stock cost basis of $1,682,507 and secured notes receivable 
investments totaling $1,073,925, which were on nonaccrual status, were 
written off.

S-Tron
- ------

The company was unsuccessful in its efforts to obtain a major 
government contract; as a result, operations will likely cease by 
early 1996.  Based on the Managing General Partner's opinion, there 
has been an other than temporary decline in the fair value of the 
Partnership's investment.  Accordingly, the Partnership has written 
off the cost basis of its Preferred stock investment of $914,127 and 
recorded a write-down of $392,015 on its subordinated note investment.

Wasatch Education Systems Corporation
- -------------------------------------

In June 1995, the Partnership converted its secured notes receivable 
totaling $2,908,450 into 2,908,450 Series C Preferred shares at $1.00 
per share.  As part of the conversion, the Partnership wrote off or 
reversed all accrued interest totaling $631,019.  In addition, the 
Partnership's existing common warrants were replaced with new five-
year warrants with similar exercise prices.  New warrants were also 
received as a result of previous maturity extensions.  The Partnership 
recorded an unrealized fair value of $217,415 to reflect the 
restricted market value of these warrants at December 31, 1995.

Other Equity Investments
- ------------------------

Biocircuits Corporation and MTI Technology Corporation are publicly-
traded companies.  All such securities are unrestricted.  All other 
equity investments not specifically discussed above are privately held 
and no public market for the sale of these securities existed at 
December 31, 1995.

7.     Secured Notes Receivable, Net
       -----------------------------

At December 31, 1995 and 1994, secured notes receivable consisted of:

<TABLE>
<CAPTION>
                                                1995        1994
                                                ----        ----
<S>                                         <C>           <C>
Secured notes receivable                    $ 7,180,478   12,069,120
Accrued interest                                  4,306      514,632
Unamortized discount                           (322,961)    (198,692)
                                              ---------   ----------
   Secured notes receivable, net 
    (cost basis)                              6,861,823   12,385,060

   Allowance for loan losses                 (4,028,000)  (3,816,000)
                                              ---------   ----------

   Secured notes receivable, net
    (fair value)                            $ 2,833,823    8,569,060
                                              =========   ==========

</TABLE>
The 1995 notes were primarily from two portfolio companies in the 
computers and computer equipment and industrial/business automation 
industries.  The remaining loans were from approximately four 
companies in a variety of industries.  All notes are secured by 
specific assets of the borrowing company.  Interest rates on secured 
notes receivable at December 31, 1995 ranged from 8.75% to 20.91%.

During 1995, $2,908,450 in secured notes and accrued interest of 
$11,091 were converted to equity investments, and secured notes 
totaling $1,073,925 were written off.  Refer to Note 6, Equity 
Investments, for disclosure regarding secured notes receivable 
converted to equity investments, write-off of secured notes 
receivable, and write-off or reversal of accrued interest.

Changes in the allowance for loan losses were as follows:

<TABLE>
<CAPTION>

                                                 1995        1994
                                                 ----        ----

<S>                                         <C>           <C>

Balance, beginning of year                  $ 3,816,000    3,677,000
                                              ---------    ---------

Provision for loan losses                     1,285,925    3,633,632

Secured notes receivable write-downs:
   Computers and computer equipment                  --   (3,465,000)
   Medical                                   (1,073,925)     (29,632)
                                              ---------    ---------
     Total write-offs                        (1,073,925)  (3,494,632)
                                              ---------    ---------

Change in net unrealized fair value of
 secured notes receivable                       212,000      139,000
                                              ---------    ---------

Balance, end of year                        $ 4,028,000    3,816,000
                                              =========    =========

</TABLE>

The provision for loan losses is generally comprised of realized 
losses, net of recognized recoveries, and a change in net unrealized 
fair value based upon the level of loan loss reserves deemed adequate 
by the Managing General Partner at the respective year ends.

Notes receivable with a total cost basis of $6,357,717 and $6,867,764 
were on nonaccrual status at December 31, 1995 and 1994, respectively, 
due to uncertainties in the financial condition of certain portfolio 
companies.  The decrease of approximately $510,000 included note 
repayments and write-downs for a portfolio company in the medical 
industry, partially offset by secured notes issued to a portfolio 
company in the computers and computer equipment industry.  The 
Managing General Partner continues to monitor the progress of these 
companies and intends to manage these investments to maximize the 
Partnership's net realizable value.  The fair value at December 31, 
1995 is based on the Managing General Partner's estimate of 
collectibility of these notes.

The allowance for loan losses is adjusted based upon changes to the 
portfolio size and risk profile.  Although the allowance for loan 
losses is established by evaluating individual debtor repayment 
ability, the allowance represents the Managing General Partner's 
assessment of the portfolio as a whole.  


The scheduled principal repayments remaining are:
<TABLE>
<CAPTION>

          Year Ending         Principal
          December 31,        Repayments
          -----------         ----------
          <S>                 <C>
             1996             $ 1,989,469
             1997                      --
             1998                      --
             1999                      --
             2000               5,191,009
                               ----------

                              $ 7,180,478
                               ==========

</TABLE>

Secured notes receivable which are due on demand are included as 
principal repayments for the year ending December 31, 1996.  In 
addition, the Managing General Partner may at times need to 
restructure notes by either extending maturity dates or converting 
notes to equity investments to increase the ultimate collectibility of 
investments to the Partnership.

8.     Cash and Cash Equivalents
       -------------------------

At December 31, 1995 and 1994, cash and cash equivalents consisted of:

<TABLE>
<CAPTION>

                                                 1995          1994
                                                 ----          ----

<S>                                         <C>             <C>
Demand and brokerage accounts               $    2,071          7,802
Money-market accounts                        7,044,551      1,914,048
                                             ---------      ---------


     Total                                  $7,046,622      1,921,850
                                             =========      =========

</TABLE>

9.     Commitments
       -----------

The Partnership is a party to financial instruments with off-balance-
sheet risk in the normal course of its business.  Generally, these 
instruments are equipment financing commitments or accounts receivable 
lines of credit that are outstanding but not currently fully utilized 
by a borrowing company.  As they do not represent current outstanding 
balances, these unfunded commitments are properly not recognized in 
the financial statements.  At December 31, 1995, the Partnership had 
unfunded commitments of $306,000 related to term note financings.

The Partnership uses the same credit policies in making these 
commitments and conditional obligations as it does for on-balance-
sheet instruments.  Commitments to extend financing are agreements to 
lend to a company as long as there are no violations of any conditions 
established in the contract.  The credit lines generally have fixed 
termination dates or other termination clauses.  Since many of the 
commitments are expected to expire without being fully drawn upon, the 
total commitment amounts do not necessarily represent future cash 
requirements.  All commitments funded require collateral specified in 
the agreements.

10.     Litigation and Other Investment Expenses
        ----------------------------------------

Other investment expenses reflect the participated cost of legal 
action between a third party and a portfolio company in the 
retail/consumer products industry.  The Partnership participated in 
investments to the portfolio company with an affiliated partnership.  
The Managing General Partner is subject to indemnification for such 
costs pursuant to the Partnership Agreement.  Accordingly, these 
expenses are excluded from the calculation of operating expense 
limitation.  At December 31, 1995, the Partnership had accrued 
expenses of approximately $82,000 for future costs to defend the case.

In late 1992, the portfolio company and the affiliated partnership 
filed a lawsuit against the third party claiming that the affiliated 
partnership had the right to take possession of collateral, the price 
paid was fair and did not interfere with the third party's legal 
rights.  The third party filed a countersuit claiming otherwise and is 
seeking relief for $2.6 million.  Currently, the portfolio company and 
the affiliated partnership have appealed a recent trial court ruling 
that absolved the affiliated partnership from wrongdoing but declared 
that the assets of the portfolio company, for a sum not certain, are 
available to satisfy certain claims of the third party.  An estimate 
of possible loss can not be determined at this time.  The Managing 
General Partner believes the Partnership has adequate defenses and 
intends to pursue this matter vigorously.  No amounts have been 
provided in the accompanying financial statements for any possible 
negative outcome of this matter.


<PAGE>
                              SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the Registrant has duly caused this Report to be 
signed on its behalf by the undersigned, thereunto duly authorized.

                         TECHNOLOGY FUNDING SECURED INVESTORS III,
                         AN INCOME AND GROWTH PARTNERSHIP, L.P.

                         By:  TECHNOLOGY FUNDING INC.
                              Managing General Partner




Date:  March 22, 1996    By:       /s/Debbie A. Wong
                              --------------------------------------
                                   Debbie A. Wong
                                   Controller

Pursuant to the requirements of the Securities Exchange Act of 1934, 
this Report has been signed below by the following persons on behalf 
of the Registrant and in the capacities and on the dates indicated:

          Signature           Capacity                   Date
          ---------           --------                   ----

   /s/Charles R. Kokesh       President, Chief       March 22, 1996
- ------------------------      Executive Officer
Charles R. Kokesh             and Chairman of
                              Technology Funding Inc.
                              and Managing General
                              Partner of Technology
                              Funding Ltd.

   /s/Gregory T. George       Group Vice President   March 22, 1996
- --------------------------    of Technology Funding
Gregory T. George             Inc. and a General
                              Partner of Technology
                              Funding Ltd.


The above represents a majority of the Board of Directors of 
Technology Funding Inc. and a majority of the General Partners of 
Technology Funding Ltd.


<TABLE> <S> <C>

<ARTICLE>6
<LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION 
EXTRACTED FROM THE FORM 10-K AS OF DECEMBER 31, 1995 AND IS QUALIFIED 
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
<MULTIPLIER>1
       
<FISCAL-YEAR-END>             DEC-31-1995
<PERIOD-START>                JAN-01-1995
<PERIOD-END>                  DEC-31-1995
<PERIOD-TYPE>                        YEAR
<INVESTMENTS-AT-COST>          10,308,829
<INVESTMENTS-AT-VALUE>          6,490,007
<RECEIVABLES>                           0
<ASSETS-OTHER>                     50,200
<OTHER-ITEMS-ASSETS>            7,046,622
<TOTAL-ASSETS>                 13,586,829
<PAYABLE-FOR-SECURITIES>                0
<SENIOR-LONG-TERM-DEBT>                 0
<OTHER-ITEMS-LIABILITIES>         810,980
<TOTAL-LIABILITIES>               810,980
<SENIOR-EQUITY>                         0
<PAID-IN-CAPITAL-COMMON>       16,594,671
<SHARES-COMMON-STOCK>             399,977
<SHARES-COMMON-PRIOR>             399,977
<ACCUMULATED-NII-CURRENT>               0
<OVERDISTRIBUTION-NII>                  0
<ACCUMULATED-NET-GAINS>                 0
<OVERDISTRIBUTION-GAINS>                0
<ACCUM-APPREC-OR-DEPREC>       (3,818,822)
<NET-ASSETS>                   12,775,849
<DIVIDEND-INCOME>                       0
<INTEREST-INCOME>               1,582,488
<OTHER-INCOME>                      6,858
<EXPENSES-NET>                    859,522
<NET-INVESTMENT-INCOME>           729,824
<REALIZED-GAINS-CURRENT>       (2,054,441)
<APPREC-INCREASE-CURRENT>       2,574,658
<NET-CHANGE-FROM-OPS>           1,250,041
<EQUALIZATION>                          0
<DISTRIBUTIONS-OF-INCOME>               0
<DISTRIBUTIONS-OF-GAINS>                0
<DISTRIBUTIONS-OTHER>             391,777
<NUMBER-OF-SHARES-SOLD>                 0
<NUMBER-OF-SHARES-REDEEMED>             0
<SHARES-REINVESTED>                     0
<NET-CHANGE-IN-ASSETS>            858,264
<ACCUMULATED-NII-PRIOR>                 0
<ACCUMULATED-GAINS-PRIOR>               0
<OVERDISTRIB-NII-PRIOR>                 0
<OVERDIST-NET-GAINS-PRIOR>              0
<GROSS-ADVISORY-FEES>             201,640
<INTEREST-EXPENSE>                      0
<GROSS-EXPENSE>                 1,587,752
<AVERAGE-NET-ASSETS>           12,346,717
<PER-SHARE-NAV-BEGIN>                  46
<PER-SHARE-NII>                        (3)
<PER-SHARE-GAIN-APPREC>                 0 <F1>
<PER-SHARE-DIVIDEND>                    0
<PER-SHARE-DISTRIBUTIONS>              (1)
<RETURNS-OF-CAPITAL>                    0
<PER-SHARE-NAV-END>                    42
<EXPENSE-RATIO>                         7
<AVG-DEBT-OUTSTANDING>                  0
<AVG-DEBT-PER-SHARE>                    0
<FN>
<F1>
A zero value is used since the change in net unrealized fair value is 
not allocated to General Partners and Limited Partners as it is not 
taxable.  Only taxable gains or losses are allocated in accordance 
with the Partnership Agreement.
</FN>

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission